825
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Enhanced transdermal delivery of loratadine from the EVA matrix

, , &
Pages 230-235 | Received 27 Oct 2008, Accepted 19 Feb 2009, Published online: 01 May 2009

References

  • Barry BW. (1983). Properties that influence percutaneous absorption. In: Barry BW, ed. Dermatological Formulations; Percutaneous Absorption. New York: Marcel Dekker, 127–233.
  • Guy RH, Hadgraft J. (1985). Transdermal drug delivery: the ground rules are emerging. Pharm Int, 6, 112.
  • Smith EW, Maibach HI. (eds) (1995). Percutaneous Penetration Enhancers. Boca Raton, FL: CRC Press, 1–50.
  • Roberts MS, Walters KA. (eds) (1998). Dermal Absorption and Toxicity Assessment. New York: Marcel Dekker, 1–785.
  • Shaw J. (1984). Pharmacokinetics of nitroglycerine and clonidine delivered by transdermal route. Am Heart J, 108, 217–22.
  • Banerjee P, Ritschal W. (1989). Transdermal permeation of vasopressin. II. Influence of Azone on in vitro and in vivo permeation. Int J Pharm, 49, 199–204.
  • Kim C, Kim J, Chi S, Shim C. (1993). Effect of fatty acids and urea on the penetration of ketoprofen through rat skin. Int J Pharm, 99, 109–18.
  • Fuhrman LC, Michniak BB, Behl CR, Malick AW. (1997). Effect of novel penetration enhancers on the transdermal delivery of hydrocortisone: an in vitro species comparison. J Contr Rel, 45, 199–206.
  • Mura P, Faucci MT, Bramanti G, Corti P. (2000). Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci, 9, 365–72.
  • Elfbaum S, Laden K. (1968). The effect of dimethyl sulphoxide on percutaneous absorption. J Soc Cosmet Chem, 19, 119–27.
  • Carelli V, Di Colo G, Nanoripieri E, Serafini M. 1993. Bile acids as enhancers of steroid penetration through excised hairless mouse skin. Int J Pharm, 89, 81–9.
  • Magnusson BM, Runn P. (1999). Effect of penetration enhancers on the permeation of the thyrotropin releasing hormone analogue pGlu-3-methyl-His-Pro amide through human epidermis. Int J Pharm, 178, 149–59.
  • Cho CW, Kim SJ, Yang KH, Song JH, Shin SC. (2008). Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer. Drug Deliv, 15, 423–8.
  • Miyazaki S, Ishii K, Sugibayashi K, Morimoto Y, Takada M. (1982). Antitumor effect of ethylene-vinyl acetate copolymer matrices containing 5-fluorouracil on Ehrlich Ascites carcinoma in mice. Chem Pharm Bull, 30, 3770.
  • Durrhein H, Flynn GL, Higuchi WI, Behl CR. (1980). Permeation of hairless mouse skin I: experimental methods and comparison with human epidermis permeation by alkanols. J Pharm Sci, 69, 781.
  • Tanojo H, Bouwstra JA, Junginger HE, Bodde HE. (1997). In vitro human skin barrier modulation by fatty acid: skin permeation and thermal analysis studies. Pharm Res, 14, 42–9.
  • Oh SY, Jeong SY, Park TG, Lee JH. (1998). Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer. J Contr Rel, 51, 161–8.
  • Elyan BM, Sidhom MB, Plakogiannis FM. (1996). Evaluation of the different fatty acids on the percutaneous absorption of metaproterenol sulfate. J Pharm Sci, 85, 101–5.
  • Takeuchi Y, Yamaoka Y, Jukushima S, Miyawaki K, Taguchi K, Yasuka H, Kishimoto S, Suzuki M. (1998). Skin penetration enhancing action of cis-unsaturated fatty acids with ω-9 and ω-12 chain lengths. Biol Pharm Bull, 21, 462–9.
  • Bhatia KS, Singh J. (1998). Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. J Pharm Sci, 87, 462–9.
  • Taguchi K, Fukushima S, Yamaoka Y, Takeuchi Y, Suzuki M. (1999). Enhancement of propylene glycol distribution in the skin by high purity cis-unsaturated fatty acids with different alkyl chain lengths having different double bond position. Biol Pharm Bull, 22, 407–11.
  • Golden GM, Mckie JE, Potts RO. (1987). Role of stratum corneum lipid fluidity in transdermal drug flux. J Pharm Sci, 76, 25–8.
  • Cooper ER. (1984). Increased skin permeability for lipophilic molecules. J Pharm Sci, 73, 1153–6.
  • Barry BW, Bennett SL. (1987). Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human-skin. J Pharm Pharmacol, 39, 535–46.
  • Guy RH, Hadgraft J. (1987). The effect of penetration enhancers on the kinetics of percutaneous absorption. J Contr Rel, 5, 43–51.
  • Kandimalla K, Kanikkannan N, Andega S, Singh M. (1999). Effect of fatty acids on the permeation of melatonin across rat and pig skin in-vitro and on the transepidermal water loss in rats in-vivo. J Pharm Pharmacol, 51, 783–90.
  • Aungst BJ, Rogers NJ, Shefter E. (1986). Enhancement of naloxon penetration through human skin in vitro using fatty acidsfatty alcohols, surfactants, sulfoxides and amides. Int J Pharm, 33, 225–34.
  • Chi SC, Park ES, Kim H. (1995). Effect of penetration enhancers on flurbiprofen permeation through rat skin. Int J Pharm, 126, 267–74.
  • Green PG, Guy RH, Hadgraft J. (1988). In vitro and in vivo enhancement of skin permeation with oleic-acid and lauric acids. Int J Pharm, 37, 251–5.
  • Ongpipattanakul B, Burnete RR, Potts RO, Francoeur ML. (1991). Evidence that oleic-acid exists in a separate phase within stratum-corneum lipids. Pharm Res, 8, 350–4.
  • Naik A, Pechtold L, Potts RO, Guy RH. (1995). Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J Contr Rel, 37, 299–306.
  • Sarpotdar PP, Zatz JL. (1986). Percutaneous absorption enhancement by nonionic surfactants. Drug Dev Ind Pharm, 12, 1625–47.
  • Cappel MJ, Kreuter J. (1991). Effect of nonionic surfactants on transdermal drug delivery: I. Polysorbates. Int J Pharm, 69, 143–53.
  • Iwasa A, Irimoto K, Kasai S, Okuyama H, Nagai T. (1991). Effect of nonionic surfactants on percutaneous absorption of diclofenac sodium. Yakuzaigaaku, 51, 16–21.
  • Lopez A, Llinares F, Cortell C, Herraez M. (2000). Comparative enhancer effects of span 20 with Tween 20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm, 202, 133–40.
  • Shin SC, Cho CW, Oh IJ. (2001). Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int J Pharm, 222, 199–203.
  • Shokri J, Nokhodchi A, Kashbolaghi A, Hassan-Zadeh K, Ghafourian T, Barzegar-Jalali M. (2001). The effect of surfactants on the skin penetration of diazepam. Int J Pharm, 228, 99–107.
  • Florence T, Tuker IG, Walters KA. (1994). Interaction of non-ionic alkyl and aryl ethers with membranes and other biological systems. In: Rosen MJ, ed. Structure Performance Relationships in Surfactants. ACS symposium Series, 253, 189–207.
  • Chowan ZT, Pritchard R. (1978). Effect of surfactants on percutaneous absorption of naproxen. I: comparisons of rabbit, rat and human excised skin. J Pharm Sci, 67, 1272–4.
  • Gao Z, Crowley WR, Shukla AJ, Johnson JR, Reger JF. 1995. Controlled release of contraceptive steroids from biodegradable and injectable gel formulations; in vivo evaluation. Pharm Res, 12, 864–8.
  • Squillante E, Needham T, Maniar A, Kislaliglu S, Zia H. (1998). Codiffusion of propylene glycol and dimethyl isosorbide in hairless mouse skin. Eur J Pharm Biopharm, 46, 265–71.
  • Adrian CW, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev, 56, 603–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.